AI Terminal
CRANEWARE PLC
Major Shareholding Notification • Jul 20, 2021
7581_mrq_2021-07-20_7e863e07-a22b-4bfb-9b4c-4edf4c95a6c3.html
Major Shareholding Notification
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8850F
Craneware plc
20 July 2021
20 July 2021
Craneware plc
("Craneware", the "Company" or the "Group")
Holding(s) in Company
Following the recent issue of shares in relation to the acquisition of SDS Holdco, Inc ('Sentry') and the resulting increase in the total issued share capital of the Company, Craneware has been notified of the following changes to the percentage holdings of the following significant shareholders in the Company:
Keith Neilson, CEO has an interest in 9.65% of the total issued share capital of the Company.
William Gordon Craig has an interest in 6.59% of the total issued share capital of the Company.
The shareholdings of Mr. Neilson and Mr. Craig remain unchanged.
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00B2425G68
Issuer Name
Craneware PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
Dilution of shareholding following issuance of shares
3. Details of person subject to the notification obligation
Name
Keith Neilson
City of registered office (if applicable)
Country of registered office (if applicable)
GB
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
14 July 2021
6. Date on which Issuer notified
16 July 2021
7. Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
| Resulting situation on the date on which threshold was crossed or reached | 9.65% | 3,429,394 | ||
| Position of previous notification (if applicable) | 10.39% | 3,429,394 |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
| GB00B2425G68 | 9.65% | |||
| Sub Total 8.A |
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
| Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
| Sub Total 8.B1 |
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
| Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
| Sub Total 8.B2 |
9. Information in relation to the person subject to the notification obligation
1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
| Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
16-Jul-2021
13. Place Of Completion
London
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00B2425G68
Issuer Name
Craneware PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
Dilution of shareholding following issuance of shares
3. Details of person subject to the notification obligation
Name
William Gordon Craig
City of registered office (if applicable)
Country of registered office (if applicable)
GB
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
14 July 2021
6. Date on which Issuer notified
16 July 2021
7. Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
| Resulting situation on the date on which threshold was crossed or reached | 6.59% | 2,342,756 | ||
| Position of previous notification (if applicable) | 7.10% | 2,342,756 |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
| GB00B2425G68 | 6.59% | |||
| Sub Total 8.A |
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
| Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
| Sub Total 8.B1 |
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
| Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
| Sub Total 8.B2 |
9. Information in relation to the person subject to the notification obligation
1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
| Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
16-Jul-2021
13. Place Of Completion
London
For further information, please contact:
| Craneware plc | +44 (0)131 550 3100 |
| Keith Neilson, CEO | |
| Craig Preston, CFO | |
| Alma (Financial PR) | +44 (0)20 3405 0205 |
| Caroline Forde, Hilary Buchanan, Robyn Fisher, Joe Pederzolli | [email protected] |
| Peel Hunt (NOMAD and Joint Broker) | +44 (0)20 7418 8900 |
| Dan Webster, George Sellar, Andrew Clark | |
| Investec Bank PLC (Joint Broker) | +44 (0)20 7597 5970 |
| Patrick Robb, Henry Reast, Sebastian Lawrence | |
| Berenberg (Joint Broker) | +44 (0)20 3207 7800 |
| Mark Whitmore, James White, Alix Mecklenburg-Solodkoff |
About Craneware
Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor financial and operational performance so they can continue to drive better outcomes for the communities they serve. Craneware's Trisus platform combines revenue integrity, cost management and decision enablement into a single SaaS-based platform. Our flagship solution, Chargemaster Toolkit®, continually earns KLAS recognition in the Revenue Cycle - Chargemaster Management category and is part of our value cycle management suite, which includes charge capture, strategic pricing, claims analytics, patient engagement, revenue recovery and retention, and cost and margin intelligence solutions.
Learn more at craneware.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLFLFSEDEIIFIL